Health Care Delivery and Financial Considerations in Amyotrophic Lateral Sclerosis Clinics: A Survey of Clinic Directors

Overview

Journal Neurology

Date 2025 Jan 30

PMID 39883905

Authors

Ilene L Hollin

Gema Giler

Terry D Heiman-Patterson

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Clinical care for people living with amyotrophic lateral sclerosis (PLWALS) is directed at slowing disease progression and symptom management. The American Academy of Neurology recommends a multidisciplinary approach to providing ALS health care because observational studies show that multidisciplinary clinics (MDCs) extend survival and improve quality of life. However, providing multidisciplinary care is a challenging financial proposition. To understand how MDCs are financed, we surveyed ALS MDCs across the Northeast ALS Consortium network in the United States.

Methods: We surveyed clinic directors in the Northeast ALS Consortium, a group of institutions equipped to provide ALS care and perform research and clinical trials in ALS. Respondents (n = 61; response rate = 49.6%) provided information regarding their care model, services, funding sources, and financial solvency between December 2020 and August 2021.

Results: In 74% (n = 45) of clinics, PLWALS were seen by the entire multidisciplinary team, and in 26% (n = 16) of clinics, PLWALS were seen by the physician and triaged according to needs. In 79% (n = 48) of clinics, visit duration was ≥3 hours, and on average, 8.4 services were available, compared with 6.8 in clinics lasting <3 hours. Most of the MDCs offer occupational (97%; n = 59), speech (97%; n = 59), and physical (95%; n = 58) therapies on site. The most common source of financial support was third-party nonprofits/philanthropy (92%; n = 56). Fifty-nine percent (n = 36) of clinics received financial support from their parent organizations (e.g., universities). Only 17% (n = 10) of clinics reported no deficit, and all clinics used multiple income sources.

Discussion: These findings reconfirm the range of services available to PLWALS and highlight the financial challenges facing ALS MDCs. The main limitation is that recruitment was through the NEALS network which primarily includes MDCs, so we were not able to compare with non-MDCs. Since not all centers responded, there may be other differences in the characteristics of the centers that did respond and those that did not leading to some bias. Future work should support the goal of reducing reliance on funding from nonprofits and increase reimbursement from payers, so health care providers can provide high-quality ALS care and cover costs.

References

Ringholz G, Appel S, Bradshaw M, Cooke N, Mosnik D, Schulz P . Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005; 65(4):586-90. DOI: 10.1212/01.wnl.0000172911.39167.b6. View

Rodriguez de Rivera F, Oreja Guevara C, Sanz Gallego I, San Jose Valiente B, Santiago Recuerda A, Gomez Mendieta M . Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit. Neurologia. 2011; 26(8):455-60. DOI: 10.1016/j.nrl.2011.01.021. View

Andersen P, Abrahams S, Borasio G, de Carvalho M, Chio A, Van Damme P . EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol. 2011; 19(3):360-75. DOI: 10.1111/j.1468-1331.2011.03501.x. View

van den Berg J, Kalmijn S, Lindeman E, Veldink J, de Visser M, van der Graaff M . Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005; 65(8):1264-7. DOI: 10.1212/01.wnl.0000180717.29273.12. View

Chio A, Bottacchi E, Buffa C, Mutani R, Mora G . Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006; 77(8):948-50. PMC: 2077622. DOI: 10.1136/jnnp.2005.083402. View

Boylan K, Levine T, Lomen-Hoerth C, Lyon M, Maginnis K, Callas P . Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters. Amyotroph Lateral Scler Frontotemporal Degener. 2015; 17(1-2):119-27. DOI: 10.3109/21678421.2015.1091478. View

Miller R, Anderson F, Brooks B, Mitsumoto H, Bradley W, Ringel S . Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol. 2009; 65 Suppl 1:S24-8. DOI: 10.1002/ana.21556. View

Traynor B, Alexander M, Corr B, Frost E, Hardiman O . Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry. 2003; 74(9):1258-61. PMC: 1738639. DOI: 10.1136/jnnp.74.9.1258. View

Salm M, Abbate K, Appelbaum P, Ottman R, Chung W, Marder K . Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training. J Genet Couns. 2013; 23(2):156-63. PMC: 3812264. DOI: 10.1007/s10897-013-9624-0. View

10.

Paganoni S, Nicholson K, Leigh F, Swoboda K, Chad D, Drake K . Developing multidisciplinary clinics for neuromuscular care and research. Muscle Nerve. 2017; 56(5):848-858. PMC: 5656914. DOI: 10.1002/mus.25725. View

11.

Mehta P, Raymond J, Punjani R, Han M, Larson T, Kaye W . Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotroph Lateral Scler Frontotemporal Degener. 2022; 24(1-2):108-116. PMC: 9568617. DOI: 10.1080/21678421.2022.2059380. View

12.

Aridegbe T, Kandler R, Walters S, Walsh T, Shaw P, McDermott C . The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener. 2012; 14(1):13-9. DOI: 10.3109/17482968.2012.690419. View

13.

Taylor L, Besbris J, Graf W, Rubin M, Cruz-Flores S, Epstein L . Clinical Guidance in Neuropalliative Care: An AAN Position Statement. Neurology. 2022; 98(10):409-416. DOI: 10.1212/WNL.0000000000200063. View

14.

Miller R, Brooks B, Swain-Eng R, Basner R, Carter G, Casey P . Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology. Neurology. 2013; 81(24):2136-40. PMC: 3863352. DOI: 10.1212/01.wnl.0000437305.37850.f9. View